Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Xiong, Yan"'
Autor:
Li Y; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA., Zhu F; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA., Manna AC; Department of Microbiology & Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Chen L; Center for Discovery and Innovation, Nutley, New Jersey, USA., Jiang J; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA., Hong JI; Department of Chemistry, Seoul National University, Seoul, South Korea., Proctor RA; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Bayer AS; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Cheung AL; Department of Microbiology & Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Xiong YQ; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Publikováno v:
Microbiology spectrum [Microbiol Spectr] 2023 Aug 17; Vol. 11 (4), pp. e0060023. Date of Electronic Publication: 2023 Jun 26.
Autor:
Huang DB; Lysovant Sciences, Inc., New York, New York, USA., Gaukel E; Lysovant Sciences, Inc., New York, New York, USA., Kerzee N; Lysovant Sciences, Inc., New York, New York, USA., Borroto-Esoda K; Lysovant Sciences, Inc., New York, New York, USA., Lowry S; Lysovant Sciences, Inc., New York, New York, USA., Xiong YQ; Department of Medicine, Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; The David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Abdelhady W; Department of Medicine, Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA., Bayer AS; Department of Medicine, Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; The David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Jul 16; Vol. 65 (8), pp. e0050821. Date of Electronic Publication: 2021 Jul 16.
Autor:
Li L; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA., Bayer AS; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Cheung A; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Lu L; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.; Division of Molecular Medicine, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA., Abdelhady W; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA., Donegan NP; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Hong JI; Department of Chemistry, Seoul National University, Seoul, Korea., Yeaman MR; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Division of Molecular Medicine, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA., Xiong YQ; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.; Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2020 Sep 01; Vol. 222 (7), pp. 1188-1198.
Autor:
Shah SU; Harbor-UCLA Medical Center, Department of Medicine, Division of Cardiology, Torrance, California, USA.; The Lundquist Institute for Biomedical Innovation (formerly the Los Angeles Biomedical Research Institute), Torrance, California, USA.; The Geffen School of Medicine at UCLA, Los Angeles, California, USA., Xiong YQ; The Lundquist Institute for Biomedical Innovation (formerly the Los Angeles Biomedical Research Institute), Torrance, California, USA.; The Geffen School of Medicine at UCLA, Los Angeles, California, USA., Abdelhady W; The Lundquist Institute for Biomedical Innovation (formerly the Los Angeles Biomedical Research Institute), Torrance, California, USA., Iwaz J; Harbor-UCLA Medical Center, Department of Medicine, Division of Cardiology, Torrance, California, USA., Pak Y; The Lundquist Institute for Biomedical Innovation (formerly the Los Angeles Biomedical Research Institute), Torrance, California, USA.; The Geffen School of Medicine at UCLA, Los Angeles, California, USA., Schuch R; ContraFect Corporation, Yonkers, New York, USA., Cassino C; ContraFect Corporation, Yonkers, New York, USA., Lehoux D; ContraFect Corporation, Yonkers, New York, USA dlehoux@contrafect.com., Bayer AS; The Lundquist Institute for Biomedical Innovation (formerly the Los Angeles Biomedical Research Institute), Torrance, California, USA.; The Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Jun 23; Vol. 64 (7). Date of Electronic Publication: 2020 Jun 23 (Print Publication: 2020).
Autor:
Xiong YQ; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Estellés A; Trellis Bioscience, LLC, Menlo Park, California, USA., Li L; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA., Abdelhady W; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA., Gonzales R; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA., Bayer AS; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Tenorio E; Trellis Bioscience, LLC, Menlo Park, California, USA., Leighton A; Trellis Bioscience, LLC, Menlo Park, California, USA., Ryser S; Trellis Bioscience, LLC, Menlo Park, California, USA., Kauvar LM; Trellis Bioscience, LLC, Menlo Park, California, USA lkauvar@trellisbio.com.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Sep 22; Vol. 61 (10). Date of Electronic Publication: 2017 Sep 22 (Print Publication: 2017).
Autor:
Xiong YQ; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at UCLA Medical Center Torrance, CA 90502, USA David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA., Yang SJ; School of Bioresources and Bioscience, Chung-Ang University, 4726 Seodong-daero, Daedeokl-myeon, Anseong-si, Gyeonggi-do 456-756 Republic of Korea., Tong SY; Menzies School of Health Research, Charles Darwin University, Darwin 0810, Australia., Alvarez DN; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at UCLA Medical Center Torrance, CA 90502, USA., Mishra NN; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at UCLA Medical Center Torrance, CA 90502, USA David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA nnmishra@ucla.edu.
Publikováno v:
Pathogens and disease [Pathog Dis] 2015 Oct; Vol. 73 (7). Date of Electronic Publication: 2015 Aug 04.
Autor:
Abdelhady W; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA., Chen L; Public Health Research Institute, NJMS-Rutgers University, Newark, NJ, USA., Bayer AS; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Seidl K; University Hospital Zurich, University of Zurich, Zurich, Switzerland., Yeaman MR; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Kreiswirth BN; Public Health Research Institute, NJMS-Rutgers University, Newark, NJ, USA., Xiong YQ; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA David Geffen School of Medicine at UCLA, Los Angeles, CA, USA yxiong@ucla.edu.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2015 May; Vol. 70 (5), pp. 1443-52. Date of Electronic Publication: 2015 Jan 05.
Autor:
Xiong YQ; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California 90502, USA. yxiong@ucla.edu, Hady WA, Deslandes A, Rey A, Fraisse L, Kristensen HH, Yeaman MR, Bayer AS
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2011 Nov; Vol. 55 (11), pp. 5325-30. Date of Electronic Publication: 2011 Aug 22.
Autor:
Yeaman MR; Division of Infectious Diseases, St. John's Cardiovascular Research Center, Harbor-UCLA Research and Education Institute, Torrance, California 90502, USA. mryeaman@ucla.edu, Cheng D, Desai B, Kupferwasser LI, Xiong YQ, Gank KD, Edwards JE Jr, Bayer AS
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2004 Aug; Vol. 48 (8), pp. 3051-6.
Autor:
Xiong, Yan Q, Li, Yi, Goncheva, Mariya I, Elsayed, Ahmed M, Zhu, Fengli, Li, Liang, Abdelhady, Wessam, Flannagan, Ronald S, Yeaman, Michael R, Bayer, Arnold S, Heinrichs, David E
Publikováno v:
Journal of Infectious Diseases; 6/15/2024, Vol. 229 Issue 6, p1648-1657, 10p